GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Brain Scientific Inc (OTCPK:BRSF) » Definitions » 14-Day RSI

Brain Scientific (Brain Scientific) 14-Day RSI : N/A (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Brain Scientific 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-06-05), Brain Scientific's 14-Day RSI is N/A.

The industry rank for Brain Scientific's 14-Day RSI or its related term are showing as below:

BRSF's 14-Day RSI is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 46.23
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Brain Scientific's 14-Day RSI

For the Medical Devices subindustry, Brain Scientific's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brain Scientific's 14-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Brain Scientific's 14-Day RSI falls into.



Brain Scientific  (OTCPK:BRSF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brain Scientific  (OTCPK:BRSF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Brain Scientific 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Brain Scientific's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Brain Scientific (Brain Scientific) Business Description

Traded in Other Exchanges
N/A
Address
6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
Executives
Morgan C. Frank 10 percent owner 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Jeb Partners, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Donald S Mackenzie director 5251 FISHER ISLAND DRIVE, MIAMI BEACH FL 33109
Thomas Olivier director C/O ARROWROOT ACQUISITION CORP., 4553 GLENCOE AVE SUITE 200, MARINA DEL REY CA 90292
Farid Anthony officer: Chief Technology Officer 12041 NW 49TH DRIVE, CORAL SPRINGS FL 33076
Daniel Danny Cloutier director 1200 MC GILL COLLEGE AVENUE, SUITE 1100, MONTREAL A8 H3G4G7
Bonnie-jeanne Gerety officer: Chief Financial Officer 5255 SOUTH TRIMBLE RD, SANDY SPRINGS GA 30342
Hassan Kotob director, 10 percent owner, officer: Chief Executive Officer 125 WILBUR PLACE, SUITE 170, C/O BRAIN SCIENTIFIC INC., BOHEMIA NY 11716
Mark Corrao officer: Chief Financial Officer 531 AIRPORT NORTH OFFICE PARK, FORT WAYNE IN 46825
Boris Goldstein director, 10 percent owner, officer: Chairman of the Board & EVP 45 WEST34 ST. 800, NEW YORK NY 10001
Nickolay V. Kukekov director 4524 WESTWAY AVE, DALLAS TX 75205